Zoetis Inc. (BMV:ZTS)

Market Cap	999.69B
Revenue (ttm)	172.36B
Net Income (ttm)	48.63B
Shares Out	n/a
EPS (ttm)	108.89
PE Ratio	20.56
Forward PE	19.24
Dividend	38.78 (1.71%)
Ex-Dividend Date	Oct 31, 2025

Volume	14
Average Volume	1,071
Open	2,265.00
Previous Close	2,253.62
Day's Range	2,265.00 - 2,265.00
52-Week Range	2,108.00 - 3,612.55
Beta	n/a
RSI	49.13
Earnings Date	Feb 13, 2026

About Zoetis

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 13,800
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: ZTS

Financial Performance

In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.

Financial numbers in USD